[1] Kahari VM,Saarialho Kere U.Matrix metalloproteinases in skin.Exp Dermatol, 1997, 6:199-213. [2] Grigioni WF,D'Errico A,Fiorentino M,et al.Gelatinase A (MMP-2) and its mRNA detected in both neoplastic and stromal cells of tumors with different invasive and metastatic properties. Diagn Mol Pathol, 1994,3:163-169. [3] Thewes M, Worret WI, Engst R, et al. Stromelysin-3 (ST-3):immunohistochemical characterization of the matrix metalloproteinase (MMP)-11 in benign and malignant skin tumours and other skin disorders. Clin Exp Dermatol, 1999,24:122-126. [4] Verdolini R, Amerio P, Goteri G, et al. Cutaneous carcinomas and preinvasive neoplastic lesions. Role of MMP-2 and MMP-9 meta lloproteinases in neoplastic invasion and their relationship with proliferative activity and p53 expression. J Cutan Pathol, 2001,28:120-126. [5] Chen X, Kanekura T, Tsuyama S, et al. Ultrastructural localization of basigin in normal human epidermis. Histochem Cell Biol, 2001,115:465-470. [6] Chen X, Kanekura T, Kanzaki T. Expression of Basigin in human fetal, infantile and adult skin and in basal cell carcinoma. J Cutaneous Pathology, 2001,28:184-190. [7] Sato T,Iwai M,Sakai T,et al.Enhancement of membrane type 1-matrix metalloproteinase (MT1-MMP) production and sequential activation of progelatinase A on human squamous carcinoma cells co cultured with human dermal fibroblasts. Br J Cancer, 1999,80:1137-1143. [8] Tokumaru Y, Fujii M, Otani Y, et al. Activation of matrix metalloproteinase-2 in head and neck squamous cell carcinoma:studies of clinical samples and in vitro cell lines co cultured with fibroblasts. Cancer Lett, 2000,150:15-21. [9] Westermarck J,Li S, Jaakkola P, et al. Activation of fibroblast collagenase-1 expression by tumor cells of squamous cell carcinomas is mediated by p38 mitogen activated protein kinase and c Jun NH2-terminal kinase-2. Cancer Res, 2000,60:7156-7162. [10] Nitta T, Sugihara K, Tsuyama S, et al. Immunohistochemical study of MUC1 mucin in premalignant oral lesions and oral squamous cell carcinoma:association with disease progression, mode of invasion, and lymph node metastasis. Cancer, 2000,888:245-254. |